CareDx, (CDNA) Forms $6.31 Double Top; Last Week Canfor (TSE:CFP) Coverage

Among 5 analysts covering Canfor Corporation (TSE:CFP), 4 have Buy rating, 1 Sell and 0 Hold. Therefore 80% are positive. Canfor Corporation had 19 analyst reports since August 21, 2015 according to SRatingsIntel. The rating was maintained by RBC Capital Markets with “Sector Perform” on Thursday, October 27. The firm earned “Outperform” rating on Thursday, October 27 by Scotia Capital. The firm earned “Outperform” rating on Friday, January 22 by BMO Capital Markets. The firm earned “Sector Perform” rating on Tuesday, January 12 by RBC Capital Markets. The firm earned “Buy” rating on Wednesday, August 31 by Dundee Securities. RBC Capital Markets downgraded it to “Underperform” rating and $17 target in Wednesday, April 19 report. The rating was downgraded by IBC to “Neutral” on Monday, April 24. The rating was maintained by TD Securities on Friday, October 28 with “Buy”. See Canfor Corporation (TSE:CFP) latest ratings:

20/10/2017 Broker: IBC Rating: Old Target: $21.00 New Target: $25.00 Target Up

CareDx, Inc (CDNA) formed double top with $6.63 target or 5.00% above today’s $6.31 share price. CareDx, Inc (CDNA) has $180.49M valuation. The stock increased 0.16% or $0.01 during the last trading session, reaching $6.31. About 147,018 shares traded. CareDx, Inc (NASDAQ:CDNA) has declined 74.10% since January 21, 2017 and is downtrending. It has underperformed by 90.80% the S&P500.

Analysts await CareDx, Inc (NASDAQ:CDNA) to report earnings on April, 20. They expect $-0.15 EPS, 0.00% or $0.00 from last year’s $-0.15 per share. After $-0.17 actual EPS reported by CareDx, Inc for the previous quarter, Wall Street now forecasts -11.76% EPS growth.

Investors sentiment increased to 1.88 in Q3 2017. Its up 1.15, from 0.73 in 2017Q2. It is positive, as 5 investors sold CareDx, Inc shares while 3 reduced holdings. 8 funds opened positions while 7 raised stakes. 6.43 million shares or 0.83% more from 6.38 million shares in 2017Q2 were reported. Tpg Group Incorporated (Sbs) Advsr, Texas-based fund reported 174,378 shares. 175,000 were accumulated by California Employees Retirement. Wells Fargo And Mn accumulated 0% or 1,139 shares. Spark Invest Management Limited Company owns 89,600 shares or 0.02% of their US portfolio. Blackrock has 7,095 shares for 0% of their portfolio. Northern Corporation has invested 0% of its portfolio in CareDx, Inc (NASDAQ:CDNA). Geode Capital Management Lc has invested 0% in CareDx, Inc (NASDAQ:CDNA). Trellus Mgmt Lc stated it has 0.14% of its portfolio in CareDx, Inc (NASDAQ:CDNA). Cambridge Investment Advisors Incorporated owns 0% invested in CareDx, Inc (NASDAQ:CDNA) for 28,575 shares. Bridgeway Cap Mgmt Incorporated holds 0.01% of its portfolio in CareDx, Inc (NASDAQ:CDNA) for 169,998 shares. 14,000 were accumulated by Teton Incorporated. Paragon Associates And Paragon Associates Ii Joint Venture reported 4.02% in CareDx, Inc (NASDAQ:CDNA). Private Wealth Prtnrs Limited Co accumulated 235,000 shares. 700 are held by Morgan Stanley. New York-based Gagnon Ltd Company has invested 2.68% in CareDx, Inc (NASDAQ:CDNA).

Among 5 analysts covering CareDx (NASDAQ:CDNA), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. CareDx has $13 highest and $3.0 lowest target. $10’s average target is 58.48% above currents $6.31 stock price. CareDx had 9 analyst reports since September 25, 2015 according to SRatingsIntel. The rating was maintained by Craig Hallum on Monday, October 9 with “Buy”. The company was downgraded on Monday, September 28 by Raymond James. The firm has “Buy” rating by Piper Jaffray given on Sunday, September 24. The stock of CareDx, Inc (NASDAQ:CDNA) has “Buy” rating given on Monday, January 8 by Piper Jaffray. The rating was maintained by Mizuho with “Buy” on Tuesday, June 14. The rating was initiated by Craig Hallum with “Buy” on Friday, September 25. The firm has “Outperform” rating by Raymond James given on Wednesday, September 27.

Free Email Newsletter

Enter your email address below to get the latest news and analysts’ ratings for your stocks with our free daily email newsletter: